Complete QTTB Stock Valuation Analysis
Comprehensive intrinsic value analysis using 1 different methodologies
QTTB Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 8 peer companies in Healthcare
P/E Ratio
$-211.87
-11251.1%
Peer Median: 54.1x
EV/EBITDA
$0.00
-100.0%
Peer Median: 0.0x
P/S Ratio
$5.59
+194.0%
Peer Median: 2.2x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for QTTB's business model and current situation.
Multiple Comparison
| Multiple | QTTB Current | Peer Median | Peer Average | Premium/Discount | Assessment |
|---|---|---|---|---|---|
| P/E Ratio | -0.5x | 54.1x | 27.1x | -100.9% | Undervalued |
| EV/EBITDA | -Infinityx | 0.0x | 0.0x | -Infinity% | Undervalued |
| P/S Ratio | 0.7x | 2.2x | 2.9x | -66.0% | Undervalued |
Peer Companies
Click any company to view their valuation
| Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
|---|---|---|---|---|
| $0.03B | 0.0x | 0.0x | 0.0x | |
| $0.02B | 0.0x | 0.0x | 2.2x | |
| $0.02B | 0.0x | 0.0x | 42.4x | |
| $0.02B | 0.1x | 0.0x | 0.7x | |
| $0.03B | 0.0x | 0.0x | 35.7x | |
| $0.02B | 0.0x | 0.0x | 8.0x | |
| $0.02B | 54.1x | 0.0x | 0.7x | |
| $0.02B | 0.0x | 0.0x | 0.0x |